MECHANISMS OF ACTION OF CANCER CHEMOTHERAPY DRUGS - ALTERNATIVE HYPOTHESIS BASED ON INHIBITION OF IMMUNOLOGICAL FUNCTION

被引:0
作者
SADOFF, L
机构
[1] SO CALIF PERMANENTE MED GRP,DEPT INTERN MED,LOS ANGELES,CA 90022
[2] KAISER FDN HOSP,DEPT MED,LOS ANGELES,CA
来源
CANCER CHEMOTHERAPY REPORTS PART 1 | 1972年 / 56卷 / 05期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:559 / 562
页数:4
相关论文
共 50 条
  • [41] TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
    Bhola, Neil E.
    Balko, Justin M.
    Dugger, Teresa C.
    Kuba, Maria Gabriela
    Sanchez, Violeta
    Sanders, Melinda
    Stanford, Jamie
    Cook, Rebecca S.
    Arteaga, Carlos L.
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (03) : 1348 - 1358
  • [42] Network Analysis Shows Novel Molecular Mechanisms of Action for Copper-Based Chemotherapy
    Espinal-Enriquez, Jesus
    Hernandez-Lemus, Enrique
    Meja, Carmen
    Ruiz-Azuara, Lena
    FRONTIERS IN PHYSIOLOGY, 2016, 6
  • [43] Anti-angiogenic drugs: direct anti-cancer agents with mitochondrial mechanisms of action
    Quayle, Lewis A.
    Pereira, Maria G.
    Scheper, Gerjan
    Wiltshire, Tammy
    Peake, Ria E.
    Hussain, Issam
    Rea, Carol A.
    Bates, Timothy E.
    ONCOTARGET, 2017, 8 (51) : 88670 - 88688
  • [44] Silymarin in cancer therapy: Mechanisms of action, protective roles in chemotherapy-induced toxicity, and nanoformulations
    Wang, Yin
    Yuan, Ai-Jun
    Wu, Yue-Jin
    Wu, Li-Mei
    Zhang, Ling
    JOURNAL OF FUNCTIONAL FOODS, 2023, 100
  • [45] Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs
    Kim, Hyun-Jung
    Bae, Suk-Chul
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2011, 3 (02): : 166 - 179
  • [46] Molecular mechanisms of platinum-based chemotherapy resistance in ovarian cancer
    Yang, Ling
    Xie, Hong-Jian
    Li, Ying-Ying
    Wang, Xia
    Liu, Xing-Xin
    Mai, Jia
    ONCOLOGY REPORTS, 2022, 47 (04)
  • [47] A review on selected herbal plants as alternative anti-diabetes drugs: chemical compositions, mechanisms of action, and clinical study
    Ahda, Mustofa
    Jaswir, Irwandi
    Khatib, Alfi
    Ahmed, Qamar Uddin
    Mahfudh, Nurkhasanah
    Ardini, Yunita Dewi
    INTERNATIONAL JOURNAL OF FOOD PROPERTIES, 2023, 26 (01) : 1414 - 1425
  • [48] ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, METHOTREXATE AND FLUOROURACIL (CMF) IN EARLY BREAST-CANCER - MECHANISMS OF ACTION
    PADMANABHAN, N
    HOWELL, A
    RUBENS, RD
    BRITISH JOURNAL OF CANCER, 1986, 53 (03) : 431 - 432
  • [49] Gold as a Possible Alternative to Platinum-Based Chemotherapy for Colon Cancer Treatment
    Marmol, Ines
    Quero, Javier
    Jesus Rodriguez-Yoldi, Maria
    Cerrada, Elena
    CANCERS, 2019, 11 (06)
  • [50] HEPATIC-FUNCTION ASSESSED (IN RATS) DURING CHEMOTHERAPY WITH SOME ANTI-CANCER DRUGS
    CAPEL, ID
    JENNER, M
    DORRELL, HM
    WILLIAMS, DC
    CLINICAL CHEMISTRY, 1979, 25 (08) : 1381 - 1383